{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:06:33Z","timestamp":1791349593502,"version":"4.3.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8,29]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Using a mouse genetic mouse model of Ph+ B-lineage ALL, endogenous antiapoptotic MCL-1 is required for leukemia survival. In BCR-ABL+ B-lineage ALL human and mouse cells, combining TKIs with small-molecule inhibitors of BCL-2 can potentiate sensitivity to cell death.<\/jats:p>","DOI":"10.1182\/blood-2012-06-440230","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T17:12:25Z","timestamp":1374685945000},"page":"1587-1598","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":90,"title":["Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"122","author":[{"given":"Brian","family":"Koss","sequence":"first","affiliation":[{"name":"Department of Biochemistry and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda M.","family":"Perciavalle","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and"},{"name":"Integrated Program in Biomedical Sciences, University of Tennessee Health Science Center, Memphis, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"},{"name":"Integrated Program in Biomedical Sciences, University of Tennessee Health Science Center, Memphis, TN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold E.","family":"Rehg","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Opferman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111819123017400_B1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrd2240","article-title":"New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.","volume":"6","author":"Pui","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2019111819123017400_B2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood-2008-04-149286","article-title":"Patients\u2019 age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group.","volume":"112","author":"Burmeister","year":"2008","journal-title":"Blood"},{"issue":"5405","key":"2019111819123017400_B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"4784","key":"2019111819123017400_B4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.3541203","article-title":"Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.","volume":"235","author":"Clark","year":"1987","journal-title":"Science"},{"issue":"5750","key":"2019111819123017400_B5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/283826a0","article-title":"Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine.","volume":"283","author":"Witte","year":"1980","journal-title":"Nature"},{"issue":"7","key":"2019111819123017400_B6","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia.","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111819123017400_B7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"issue":"24","key":"2019111819123017400_B8","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMe068073","article-title":"Circumventing resistance to kinase-inhibitor therapy.","volume":"354","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"5517","key":"2019111819123017400_B9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"issue":"17","key":"2019111819123017400_B10","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","article-title":"An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9.","volume":"274","author":"Zou","year":"1999","journal-title":"J Biol Chem"},{"issue":"5","key":"2019111819123017400_B11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"17","key":"2019111819123017400_B12","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1073\/pnas.0602030103","article-title":"Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.","volume":"103","author":"Williams","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2019111819123017400_B13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1101\/gad.1588607","article-title":"Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia.","volume":"21","author":"Williams","year":"2007","journal-title":"Genes Dev"},{"issue":"6967","key":"2019111819123017400_B14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"issue":"32","key":"2019111819123017400_B15","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1073\/pnas.0504783102","article-title":"Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.","volume":"102","author":"Takeuchi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111819123017400_B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"issue":"8","key":"2019111819123017400_B17","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1210\/en.2007-0261","article-title":"Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities.","volume":"148","author":"Guo","year":"2007","journal-title":"Endocrinology"},{"issue":"6","key":"2019111819123017400_B18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ncb2488","article-title":"Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration.","volume":"14","author":"Perciavalle","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2019111819123017400_B19","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V69.4.990.990","article-title":"Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia.","volume":"69","author":"Okabe","year":"1987","journal-title":"Blood"},{"issue":"7","key":"2019111819123017400_B20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.V83.7.1731.1731","article-title":"Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia.","volume":"83","author":"Manabe","year":"1994","journal-title":"Blood"},{"issue":"3","key":"2019111819123017400_B21","first-page":"447","article-title":"Establishment of a Ph1-positive human cell line (BV173).","volume":"70","author":"Pegoraro","year":"1983","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2019111819123017400_B22","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/MCB.01266-09","article-title":"Ubiquitin-independent degradation of antiapoptotic MCL-1.","volume":"30","author":"Stewart","year":"2010","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019111819123017400_B23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.1673908","article-title":"Failure of CDKN2A\/B (INK4A\/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.","volume":"22","author":"Mullighan","year":"2008","journal-title":"Genes Dev"},{"issue":"14","key":"2019111819123017400_B24","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","article-title":"Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.","volume":"24","author":"Kuribara","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"14","key":"2019111819123017400_B25","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","article-title":"Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.","volume":"24","author":"Essafi","year":"2005","journal-title":"Oncogene"},{"issue":"40","key":"2019111819123017400_B26","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.","volume":"103","author":"Kuroda","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111819123017400_B27","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","article-title":"STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells.","volume":"95","author":"Sillaber","year":"2000","journal-title":"Blood"},{"issue":"12","key":"2019111819123017400_B28","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1074\/mcp.M900285-MCP200","article-title":"Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.","volume":"8","author":"Pan","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"2019111819123017400_B29","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res"},{"issue":"12","key":"2019111819123017400_B30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"2019111819123017400_B31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.","volume":"30","author":"Roberts","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111819123017400_B32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111819123017400_B33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized.","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"issue":"16","key":"2019111819123017400_B34","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1182\/blood-2009-07-233304","article-title":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.","volume":"115","author":"Yecies","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111819123017400_B35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J Clin Invest"},{"issue":"23","key":"2019111819123017400_B36","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/MCB.01481-08","article-title":"Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.","volume":"29","author":"Chen","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2019111819123017400_B37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"issue":"5813","key":"2019111819123017400_B38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.","volume":"315","author":"Willis","year":"2007","journal-title":"Science"},{"issue":"7","key":"2019111819123017400_B39","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2007-08-108803","article-title":"Loss of Bcl-x in Ph+ B-ALL increases cellular proliferation and does not inhibit leukemogenesis.","volume":"111","author":"Harb","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111819123017400_B40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-11-1440","article-title":"Tipping the Noxa\/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.","volume":"18","author":"Tromp","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019111819123017400_B41","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1172\/JCI39964","article-title":"Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.","volume":"120","author":"Xiang","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111819123017400_B42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev"},{"issue":"8","key":"2019111819123017400_B43","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"issue":"5712","key":"2019111819123017400_B44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.","volume":"307","author":"Opferman","year":"2005","journal-title":"Science"},{"issue":"12","key":"2019111819123017400_B45","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2008-05-159145","article-title":"Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function.","volume":"113","author":"Steimer","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111819123017400_B46","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/MCB.18.8.4883","article-title":"mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response.","volume":"18","author":"Chao","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"26","key":"2019111819123017400_B47","doi-asserted-by":"crossref","first-page":"26915","DOI":"10.1074\/jbc.M313875200","article-title":"Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1.","volume":"279","author":"Derouet","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"2019111819123017400_B48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1101\/gad.1093903","article-title":"Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.","volume":"17","author":"Nijhawan","year":"2003","journal-title":"Genes Dev"},{"issue":"7","key":"2019111819123017400_B49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"},{"issue":"7277","key":"2019111819123017400_B50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"issue":"9","key":"2019111819123017400_B51","first-page":"2976","article-title":"Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.","volume":"8","author":"Yu","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019111819123017400_B52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jnci\/djn076","article-title":"Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.","volume":"100","author":"Kang","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2019111819123017400_B53","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-08-2978","article-title":"Sorafenib induces apoptosis specifically in cells expressing BCR\/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.","volume":"69","author":"Kurosu","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2019111819123017400_B54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1158\/0008-5472.CAN-06-3964","article-title":"Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"2019111819123017400_B55","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1371\/journal.pmed.0040316","article-title":"Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.","volume":"4","author":"Cragg","year":"2007","journal-title":"PLoS Med"},{"issue":"1","key":"2019111819123017400_B56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molonc.2010.10.003","article-title":"Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells.","volume":"5","author":"Reynoso","year":"2011","journal-title":"Mol Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/9\/1587\/1373459\/1587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/9\/1587\/1373459\/1587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:43:50Z","timestamp":1574124230000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/122\/9\/1587\/32196\/Requirement-for-antiapoptotic-MCL1-in-the-survival"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,8,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-440230","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}